ARWR  valuation analysis

Basics
Name: Arrowhead Pharmaceuticals, Inc
Description: Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 04, 2021
Market cap: $7.09B (357th)
Sales(TTM): $79.84M (835th)
Earnings(TTM): -$102.61M (735th)

Value
FFER: 5.61*
Actual price: $68.70
* Earnings were reported May 05, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-05-12
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Arrowhead Pharmaceuticals, Inc's earnings decreased from $53.26M to -$102.61M in the last year.
  • Arrowhead Pharmaceuticals, Inc's operating income decreased from $45.39M to -$112.36M in the last year.
Earnings / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Sales / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Book / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Equity / Assets
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry